Skip to main content

CVS

  • Issues Summit panels attract record attendance

    Record-breaking attendance and four panel discussions on such topics as specialty pharmacy and diabetes set the stage for the 13th annual Drug Store News Industry Issues Summit held on Nov. 29 in New York City. This year’s event attracted more than 30 retailers and 200 industry suppliers. 


  • 10 Keys: CVS Caremark looks to unlock full potential, reinvent Rx

    CVS Caremark is reinventing pharmacy and unlocking the full potential of its distinctive model. The company is doing this by capitalizing on what Larry Merlo, president and CEO, has referred to as “integration sweet spots,” which are capabilities unique to CVS Caremark’s integrated model. In this issue of DSN, we explore what we believe are 10 keys to driving growth across CVS' network and transforming the retail health landscape.

  • Analysts provide outlook for 2012

    NEW YORK — A wide range of factors and "moving parts" will likely make 2012 a challenging year for pharmacy retailers as the economy, generic drugs and the dispute between Walgreens and Express Scripts figure prominently, analysts say.

    Still, they say, various factors may serve to benefit drug stores and other retailers that operate pharmacies.

  • CVS/pharmacy enhances 'Send to Card' digital options

    WOONSOCKET, R.I. — CVS/pharmacy's ExtraCare Rewards program now enables ExtraCare cardholders to send their quarterly ExtraBucks Rewards to their ExtraCare cards, eliminating the need for shoppers to carry paper rewards into their local CVS/pharmacy.

  • FTC ends investigation of CVS Caremark

    WOONSOCKET, R.I. — CVS Caremark announced on Thursday that the Federal Trade Commission has concluded its investigation into the company’s business practices.

  • CVS Caremark's Helena Foulkes outlines integrated pharmacy-based program at forum

    WASHINGTON — CVS Caremark's chief healthcare strategy officer on Tuesday outlined how the company's integrated pharmacy-based program for such chronic diseases as diabetes, called Pharmacy Advisor, increased medication adherence rates and physician initiation of prescriptions for concomitant medications to improve patient health.

  • CVS Caremark looks to purchase Health Net's stand-alone Medicare Part D Rx drug plan business

    LOS ANGELES and WOONSOCKET, R.I. — CVS Caremark has entered into a definitive agreement to purchase the stand-alone Medicare Part D prescription drug plan business from Health Net for approximately $160 million in cash.

    The transaction is anticipated to close in the second quarter of 2012, subject to customary closing conditions and applicable regulatory approvals, including approval from the Centers for Medicare and Medicaid Services.

  • CVS Caremark study: Pharmacy Advisor improved diabetes Rx initiation, adherence rates

    WOONSOCKET, R.I. — A CVS Caremark study found that the company's integrated pharmacy-based program — Pharmacy Advisor — increased medication adherence rates and physician initiation of prescriptions for concomitant medications, improving care for diabetes patients and resulting in savings for health plans, the company announced on Monday.

X
This ad will auto-close in 10 seconds